Function of retinoid nuclear receptors: Lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis

Annual Review of Pharmacology and Toxicology

Volumn 46, Issue , 2006, Pages 451-480

  Mark, Manuel ^a   Ghyselinck, Norbert B ^a   Chambon, Pierre ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Activation function; Heterodimers; Knockout; RAR; RXR; Teratogenesis

Indexed keywords

CELL NUCLEUS RECEPTOR; HETERODIMER; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA; RETINOID X RECEPTOR; RETINOID X RECEPTOR ALPHA;

BODY GROWTH; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CHEMICAL MUTAGENESIS; CONGENITAL MALFORMATION; DIMERIZATION; EMBRYO DEVELOPMENT; EYE DEVELOPMENT; GENOTYPE; HOMEOSTASIS; MORPHOGENESIS; MOUSE; NONHUMAN; ORGANOGENESIS; PHYLOGENY; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REVIEW; RHOMBENCEPHALON; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TERATOGENESIS;

ANIMALS; EMBRYONIC DEVELOPMENT; FEMALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTAGENESIS; MUTAGENS; PREGNANCY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; SIGNAL TRANSDUCTION; TERATOGENS;

VERTEBRATA;

EID: 33144488245     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.46.120604.141156     Document Type: Review

References (161)

1. Blomhoff R. 1994. Transport and metabolism of vitamin A. Nutr. Rev. 52:S13-23
2. Sporn MB, Roberts AB, Goodman DS. 1994. The Retinoids. Biology, Chemistry and Medicine. New York: Raven. 2nd ed.
3. Kastner P, Mark M, Chambon P. 1995. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-69
4. Morriss-Kay GM, Ward SJ. 1999. Retinoids and mammalian development. Int. Rev. Cytol. 188:73-131
5. Hale F. 1933. Pigs born without eyeballs. J. Hered. 24:105-6
6. Wilson JG, Roth CB, Warkany J. 1953. An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation. Am. J. Anat. 92:189-217
7. Wolbach SB, Howe PR. 1925. Tissue changes following deprivation of fat-soluble A vitamin. J. Exp. Med. 42:753-77
8. Corcoran J, So PL, Barber RD, Vincent KJ, Mazarakis ND, et al. 2002. Absence of retinoids can induce motoneuron disease in the adult rat and a retinoid defect is present in motoneuron disease patients. J. Cell Sci. 115:4735-41
9. Thompson JN, Howell JM, Pitt GA. 1964. Vitamin A and reproduction in rats. Proc. R. Soc. London B 159:510-35
10. Dickman ED, Thaller C, Smith SM. 1997. Temporally-regulated retinoic acid depletion produces specific neural crest, ocular and nervous system defects. Development 124:3111-21
11. White JC, Shankar VN, Highland M, Epstein ML, DeLuca HF, et al. 1998. Defects in embryonic hindbrain development and fetal resorption resulting from vitamin A deficiency in the rat are prevented by feeding pharmacological levels of all-trans-retinoic acid. Proc. Natl. Acad. Sci. USA 95:13459-64
12. Chambon P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:940-54
13. Leid M, Kastner P, Chambon P. 1992. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci. 17:427-33
14. Laudet V, Gronemeyer H. 2002. The Nuclear Receptor Facts Book. London: Academic
15. Rochette-Egly C, Chambon P. 2001. F9 embryocarcinoma cells: a cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signalling. Histol. Histopathol. 16:909-22
16. Rochette-Egly C. 2003. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell. Signal. 15:355-66
17. Moras D, Gronemeyer H. 1998. The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10:384-91
18. Glass CK, Rosenfeld MG. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:121-41
19. Egea PF, Klaholz BP, Moras D. 2000. Ligand-protein interactions in nuclear receptors of hormones. FEBS Lett. 476:62-67
20. Germain P, Iyer J, Zechel C, Gronemeyer H. 2002. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 15:187-92
21. Nagpal S, Saunders M, Kastner P, Durand B, Nakshatri H, et al. 1992. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70:1007-19
22. Nagpal S, Friant S, Nakshatri H, Chambon P. 1993. RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo. EMBO J. 12:2349-60
23. Mangelsdorf DJ, Evans RM. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-50
24. Gronemeyer H, Gustafsson JA, Laudet V. 2004. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug. Discov. 3:950-64
25. Chambon P. 2005. The nuclear receptor superfamily: a personal retrospect on the two first decades. Mol. Endocrinol. 19:1418-28
26. Mata de Urquiza A, Liu S, Sjöberg M, Zetterström RH, Griffiths W, et al. 2000. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290:2140-44
27. Goldstein JT, Dobrzyn A, Clagett-Dame M, Pike JW, DeLuca HF. 2003. Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor. Arch. Biochem. Biophys. 420:185-93
28. Lengqvist J, Mata De Urquiza A, Bergman AC, Willson TM, Sjovall J, et al. 2004. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol. Cell. Proteomics 3:692-703
29. Escriva H, Bertrand S, Laudet V. 2004. The evolution of the nuclear receptor superfamily. Essays Biochem. 40:11-26
30. Kastner P, Mark M, Ghyselinck NB, Krezel W, Dupé V, et al. 1997. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 124:313-26
31. Ghyselinck NB, Dupé V, Dierich A, Messaddeq N, Garnier JM, et al. 1997. Role of the retinoic acid receptor beta (RAR-beta) during mouse development. Int. J. Dev. Biol. 41:425-47
32. Mascrez B, Mark M, Dierich A, Ghyselinck N, Kastner P, et al. 1998. The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. Development 125:4691-707
33. Luo J, Sucov HM, Bader JA, Evans RM, Giguere V. 1996. Compound mutants for retinoic acid receptor (RAR) beta and RAR alpha 1 reveal developmental functions for multiple RAR beta isoforms. Mech. Dev. 55:33-44
34. Grondona JM, Kastner P, Gansmuller A, Décimo D, Chambon P, et al. 1996. Retinal dysplasia and degeneration in RARbeta2/RARgamma2 compound mutant mice. Development 122:2173-88
35. Subbarayan V, Kastner P, Mark M, Dierich A, Gorry P, et al. 1997. Limited specificity and large overlap of the functions of the mouse RAR gamma 1 and RAR gamma 2 isoforms. Mech. Dev. 66:131-42
36. Ghyselinck NB, Wendling O, Messaddeq N, Dierich A, Lampron C, et al. 1998. Contribution of retinoic acid receptor beta isoforms to the formation of the conotruncal septum of the embryonic heart. Dev. Biol. 198:303-18
37. Lohnes D, Mark M, Mendelsohn C, Dollé P, Dierich A, et al. 1994. Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. Development 120:2723-48
38. Lohnes D, Kastner P, Dierich A, Mark M, LeMeur M, et al. 1993. Function of retinoic acid receptor gamma in the mouse. Cell 73:643-58
39. Mendelsohn C, Lohnes D, Décimo D, Lufkin T, LeMeur M, et al. 1994. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120:2749-71
40. White JC, Highland M, Kaiser M, Clagett-Dame M. 2000. Vitamin A deficiency results in the dose-dependent acquisition of anterior character and shortening of the caudal hindbrain of the rat embryo. Dev. Biol. 220:263-84
41. Niederreither K, Subbarayan V, Dollé P, Chambon P. 1999. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nat. Genet. 21:444-48
42. Niederreither K, Vermot J, Schuhbaur B, Chambon P, Dollé P. 2000. Retinoic acid synthesis and hindbrain patterning in the mouse embryo. Development 127:75-85
43. Niederreither K, Vermot J, Messaddeq N, Schuhbaur B, Chambon P, et al. 2001. Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse. Development 128:1019-31
44. Niederreither K, Vermot J, Schuhbaur B, Chambon P, Dollé P. 2002. Embryonic retinoic acid synthesis is required for forelimb growth and anteroposterior patterning in the mouse. Development 129:3563-74
45. Mic FA, Duester G. 2003. Patterning of forelimb bud myogenic precursor cells requires retinoic acid signalling initiated by Raldh2. Dev. Biol. 264:191-201
46. Mic FA, Sirbu IO, Duester G. 2004. Retinoic acid synthesis controlled by Raldh2 is required early for limb bud initiation and then later as a proximodistal signal during apical ectodermal ridge formation. J. Biol. Chem. 279:26698-706
47. Dupé V, Matt N, Garnier JM, Chambon P, Mark M, et al. 2003. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment. Proc. Natl. Acad. Sci. USA 100:14036-41
48. Wendung O, Dennefeld C, Chambon P, Mark M. 2000. Retinoid signalling is essential for patterning the endoderm of the third and fourth pharyngeal arches. Development 127:1553-62
49. Wendling O, Ghyselinck NB, Chambon P, Mark M. 2001. Roles of retinoic acid receptors in early embryonic morphogenesis and hindbrain patterning. Development 128:2031-38
50. Kochhar DM, Jiang H, Penner JD, Johnson AT, Chandraratna RA. 1998. The use of a retinoid receptor antagonist in a new model to study vitamin A-dependent developmental events. Int. J. Dev. Biol. 42:601-8
51. Mark M, Lohnes D, Mendelsohn C, Dupé V, Vonesch JL, et al. 1995. Roles of retinoic acid receptors and of Hox genes in the patterning of the teeth and of the jaw skeleton. Int. J. Dev. Biol. 39:111-21
52. Mark M, Ghyselinck N, Kastner P, Dupé V, Wendling O, et al. 1998. Mesectoderm is a major target of retinoic acid action. Eur. J. Oral Sci. 106(Suppl. 1):24-31
53. Dupé V, Ghyselinck NB, Wendling O, Chambon P, Mark M. 1999. Key roles of retinoic acid receptors alpha and beta in the patterning of the caudal hindbrain, pharyngeal arches and otocyst in the mouse. Development 126:5051-59
54. Dupé V, Davenne M, Brocard J, Dollé P, Mark M, et al. 1997. In vivo functional analysis of the Hoxa-1 3′ retinoic acid response element (3́RARE). Development 124:399-410
55. Houle M, Prinos P, Iulianella A, Bouchard N, Lohnes D. 2000. Retinoic acid regulation of Cdx1: an indirect mechanism for retinoids and vertebral specification. Mol Cell. Biol. 20:6579-86
56. Allan D, Houle M, Bouchard N, Meyer BI, Gruss P, et al. 2001. RARgamma and Cdx1 interactions in vertebral patterning. Dev. Biol. 240:46-60
57. Oosterveen T, Niederreither K, Dollé P, Chambon P, Meijlink F, et al. 2003. Retinoids regulate the anterior expression boundaries of 5′ Hoxb genes in posterior hindbrain. EMBO J. 22:262-69
58. Serpente P, Tumpel S, Ghyselinck NB, Niederreither K, Wiedemann LM, et al. 2005. Direct crossregulation between retinoic acid receptor {beta} and Hox genes during hindbrain segmentation. Development 132:503-13
59. Dupé V, Ghyselinck NB, Thomazy V, Nagy L, Davies PJA, et al. 1999. Essential roles of retinoic acid signalling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. Dev. Biol. 208:30-43
60. Kastner P, Messaddeq N, Mark M, Wendling O, Grondona JM, et al. 1997. Vitamin A deficiency and mutations of RXRalpha, RXRbeta and RARalpha lead to early differentiation of embryonic ventricular cardiomyocytes. Development 124:4749-58
61. Crocoll A, Herzer U, Ghyselinck NB, Chambon P, Cato AC. 2002. Interdigital apoptosis and downregulation of BAG-1 expression in mouse autopods. Mech. Dev. 111:149-52
62. Mendelsohn C, Batourina E, Fung S, Gilbert T, Dodd J. 1999. Stromal cells mediate retinoid-dependent functions essential for renal development. Development 126:1139-48
63. Batourina E, Gim S, Bello N, Shy M, Clagett-Dame M, et al. 2001. Vitamin A controls epithelial/mesenchymal interactions through Ret expression. Nat. Genet. 27:74-78
64. Batourina E, Choi C, Paragas N, Bello N, Hensle T, et al. 2002. Distal ureter morphogenesis depends on epithelial cell remodeling mediated by vitamin A and Ret. Nat. Genet. 32:109-15
65. Mollard R, Ghyselinck NB, Wendling O, Chambon P, Mark M. 2000. Stage-dependent responses of the developing lung to retinoic acid signalling. Int. J. Dev. Biol. 44:457-62
66. Malpel S, Mendelsohn C, Cardoso WV. 2000. Regulation of retinoic acid signalling during lung morphogenesis. Development 127:3057-67
67. Massaro GD, Massaro D, Chan WY, Clerch LB, Ghyselinck N, et al. 2000. Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli. Physiol. Genomics 4:51-57
68. McGowan S, Jackson SK, Jenkins-Moore M, Dai HH, Chambon P, et al. 2000. Mice bearing deletions of retinoic acid receptors demonstrate reduced lung elastin and alveolar numbers. Am. J. Respir. Cell Mol. Biol. 23:162-67
69. Massaro GD, Massaro D, Chambon P. 2003. Retinoic acid receptor-alpha regulates pulmonary alveolus formation in mice after, but not during, perinatal period. Am. J. Physiol. Lung Cell Mol. Physiol. 284:L431-33
70. Massaro D, Massaro GD. 2003. Retinoids, alveolus formation, and alveolar deficiency: clinical implications. Am. J. Respir. Cell Mol. Biol. 28:271-74
71. Novacek MJ. 1993. Patterns of diversity in mammalian skull. In The Skull, ed. J Hanken, BK Hall, pp. 438-548. Chicago: Univ. Chicago Press
72. Kingsley DM. 1994. What do BMPs do in mammals? Clues from the mouse short-ear mutation. Trends Genet. 10:16-21
73. Hogan BL. 1996. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10:1580-94
74. Helms JA, Cordero D, Tapadia MD. 2005. New insights into craniofacial morphogenesis. Development 132:851-61
75. Mann I. 1937. Developmental Abnormalities of the Eye. Cambridge, UK: Cambridge Univ. Press
76. Kastner P, Grondona JM, Mark M, Gansmuller A, LeMeur M, et al. 1994. Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signalling pathways in heart and eye morphogenesis. Cell 78:987-1003
77. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, et al. 1994. RXR alpha mutant mice establish a genetic basis for vitamin A signalling in heart morphogenesis. Genes Dev. 8:1007-18
78. -/- embryos. Development 125:533-44
79. Subbarayan V, Mark M, Messadeq N, Rustin P, Chambon P, et al. 2000. RXRalpha overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRalpha-null fetuses. J. Clin. Invest. 105:387-94
80. Chen T, Chang T, Kang J, Choudhary B, Makita T, et al. 2002. Epicardial induction of fetal cardiomyocyte proliferation via a retinoic acid-inducible trophic factor. Dev. Biol. 250:198-207
81. Kang JO, Sucov HM. 2005. Convergent proliferative response and divergent morphogenic pathways induced by epicardial and endocardial signalling in fetal heart development. Mech. Dev. 122:57-65
82. Krezel W, Dupé V, Mark M, Dierich A, Kastner P, et al. 1996. RXR gamma null mice are apparently normal and compound RXR alpha+/-/RXR beta-/-/RXR gamma-/- mutant mice are viable. Proc. Natl. Acad. Sci. USA 93:9010-14
83. Mascrez B, Mark M, Krezel W, Dupé V, LeMeur M, et al. 2001. Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha. Development 128:2049-62
84. Mascrez B, Ghyselinck NB, Chambon P, Mark M. 2005. A transcriptionally silent RXRalpha supports early embryonic morphogenesis and heart development. Proc. Natl. Acad. Sci. USA. In press
85. Kastner P, Mark M, Leid M, Gansmuller A, Grondona JM, et al. 1996. Abnormal spermatogenesis in RXR beta mutant mice. Genes Dev. 10:80-92
86. Horton C, Maden M. 1995. Endogenous distribution of retinoids during normal development and teratogenesis in the mouse embryo. Dev. Dyn. 202:312-23
87. Matt N, Schmidt CK, Dupé V, Dennefeld C, Nau H, et al. 2005. Contribution of cellular retinol-binding protein type 1 to retinol metabolism during mouse development. Dev. Dyn. 233:167-76
88. Lussier M, Canoun C, Ma C, Sank A, Shuler C. 1993. Interdigital soft tissue separation induced by retinoic acid in mouse limbs cultured in vitro. Int. J. Dev. Biol. 37:555-64
89. Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, et al. 1993. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc. Natl. Acad. Sci. USA 90:7225-29
90. Bastien J, Adam-Stitah S, Plassat JL, Chambon P, Rochette-Egly C. 2002. The phosphorylation site located in the A region of retinoic X receptor alpha is required for the antiproliferative effect of retinoic acid (RA) and the activation of RA target genes in F9 cells. J. Biol. Chem. 277:28683-89
91. Mori M, Ghyselinck NB, Chambon P, Mark M. 2001. Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes. Invest. Ophthalmol. Vis. Sci. 42:1312-18
92. Mark M, Ghyselinck NB, Chambon P. 2004. Retinoic acid signalling in the development of branchial arches. Curr. Opin. Genet. Dev. 14:591-98
93. Dupé V, Lumsden A. 2001. Hindbrain patterning involves graded responses to retinoic acid signalling. Development 128:2199-208
94. MacLean G, Abu-Abed S, Dollé P, Tahayato A, Chambon P, et al. 2001. Cloning of a novel retinoic-acid metabolizing cytochrome P450, Cyp26B1, and comparative expression analysis with Cyp26A1 during early murine development. Mech. Dev. 107:195-201
95. Abu-Abed S, Dollé P, Metzger D, Beckett B, Chambon P, et al. 2001. The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. Genes Dev. 15:226-40
96. Tahayato A, Dollé P, Petkovich M. 2003. Cyp26C21 encodes a novel retinoic acid-metabolizing enzyme expressed in the hindbrain, inner ear, first branchial arch and tooth buds during murine development. Gene Expr. Patterns 3:449-54
97. Metzger D, Chambon P. 2001. Site- and time-specific gene targeting in the mouse. Methods 24:71-80
98. Matt N, Dupé V, Gamier JM, Dennefeld C, Chambon P, et al. 2005. The retinoic acid-dependent eye morphogenesis is orchestrated by neural crest cells. Development. 132:4789-800
99. Cvekl A, Tamm ER. 2004. Anterior eye development and ocular mesenchyme: new insights from mouse models and human diseases. Bioessays 26:374-86
100. Soprano DR, Soprano KJ. 1995. Retinoids as teratogens. Annu. Rev. Nutr. 15:111-32
101. Collins MD, Mao GE. 1999. Teratology of retinoids. Annu. Rev. Pharmacol. Toxicol. 39:399-430
102. Escriva H, Holland ND, Gronemeyer H, Laudet V, Holland LZ. 2002. The retinoic acid signalling pathway regulates anterior/posterior patterning in the nerve cord and pharynx of amphioxus, a chordate lacking neural crest. Development 129:2905-16
103. Kochhar DM, Jiang H, Penner JD, Beard RL, Chandraratna AS. 1996. Differential teratogenic response of mouse embryos to receptor selective analogs of retinoic acid. Chem. Biol. Interact. 100:1-12
104. Elmazar MM, Reichert U, Shroot B, Nau H. Elmazar MM, et al. 1996. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma. Teratology 53:158-67
105. Arafa HM, Elmazar MM, Hamada FM, Reichert U, Shroot B, et al. 2000. Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure. Arch. Toxicol. 73:547-56
106. Old RW, Smith DP, Mason CS, Marklew S, Jones EA. 1996. Effects of retinoic acid on Xenopus embryos. Biochem. Soc. Symp. 62:157-74
107. Blumberg B, Bolado J Jr, Moreno TA, Kintner C, Evans RM, et al. 1997. An essential role for retinoid signalling in anteroposterior neural patterning. Development 124:373-79
108. van der Wees J, Schilthuis JG, Koster CH, Diesveld-Schipper H, Folkers GE, et al. 1998. Inhibition of retinoic acid receptor-signalling alters positional identity in the developing hindbrain. Development 125:545-56
109. Sucov HM, Izpisua-Belmonte JC, Ganan Y, Evans RM. 1995. Mouse embryos lacking RXR alpha are resistant to retinoic-acid-induced limb defects. Development 21:3997-4003
110. Iulianella A, Lohnes D. 1997. Contribution of retinoic acid receptor gamma to retinoid-induced craniofacial and axial defects. Dev. Dyn. 209:92-104
111. Nugent P, Sucov HM, Pisano M, Green RM. 1999. The role of RXR-alpha in retinoic acid-induced cleft palate as assessed with the RXR-alpha knockout mouse. Int. J. Dev. Biol. 43:567-70
112. Abu-Abed S, Dollé P, Metzger D, Wood C, MacLean G, et al. 2003. Developing with lethal RA levels: genetic ablation of Rarg can restore the viability of mice lacking Cyp26a1. Development 130:1449-59
113. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, et al. 1985. Retinoic acid embryopathy. N. Engl. J. Med. 313:837-41
114. Pratt RM, Goulding EH, Abbott BD. 1987. Retinoic acid inhibits migration of cranial neural crest cells in the cultured mouse embryo. J. Craniofac. Genet. Dev. Biol 7:205-17
115. Lee YM, Osumi-Yamashita N, Ninomiya Y, Moon CK, Eriksson U, et al. 1995. Retinoic acid stage-dependently alters the migration pattern and identity of hindbrain neural crest cells. Development 121:825-37
116. Matt N, Ghyselinck NB, Wendling O, Chambon P, Mark M. 2003. Retinoic acid-induced developmental defects are mediated by RARbeta/RXR heterodimers in the pharyngeal endoderm. Development 130:2083-93
117. Elmazar MM, Ruhl R, Reichert U, Shroot B, Nau H. 1997. RARalpha-mediated teratogenicity in mice is potentiated by an RXR agonist and reduced by an RAR antagonist: dissection of retinoid receptor-induced pathways. Toxicol. Appl. Pharmacol. 146:21-28
118. Elmazar MM, Ruhl R, Nau H. 2001. Synergistic teratogenic effects induced by retinoids in mice by coadministration of a RARalpha- or RARgamma-selective agonist with a RXR-selective agonist. Toxicol. Appl. Pharmacol. 170:2-9
119. Wiley MJ, Cauwenbergs P, Taylor IM. 1983. Effects of retinoic acid on the development of the facial skeleton in hamsters: early changes involving cranial neural crest cells. Acta. Anat. (Basel) 116:180-92
120. Taimi M, Helvig C, Wisniewski J, Ramshaw H, White J, et al. 2004. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J. Biol. Chem. 279:77-85
121. Pijnappel WW, Hendriks HF, Folkers GE, van den Brink CE, Dekker EJ, et al. 1993. The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification. Nature 366:340-44
122. Satre MA, Penner JD, Kochhar DM. 1989. Pharmacokinetic assessment of teratologically effective concentrations of an endogenous retinoic acid metabolite. Teratology 39:341-48
123. Niederreither K, Abu-Abed S, Schuhbaur B, Petkovich M, Chambon P, et al. 2002. Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signalling during mouse development. Nat. Genet. 31:84-88
124. Sulik KK, Dehart DB, Rogers JM, Chernoff N. 1995. Teratogenicity of low doses of all-trans retinoic acid in presomite mouse embryos. Teratology 51:398-403
125. Rutledge JC, Shourbaji AG, Hughes LA, Polifka JE, Cruz YP, et al. 1994. Limb and lower-body duplications induced by retinoic acid in mice. Proc. Natl. Acad. Sci. USA 91:5436-40
126. Niederreither K, Ward SJ, Dollé P, Chambon P. 1996. Morphological and molecular characterization of retinoic acid-induced limb duplications in mice. Dev. Biol. 176:185-98
127. Huang FJ, Hsu YC, Kang HY, Chang SY, Hsuuw YD, et al. 2005. Effects of retinoic acid on the inner cell mass in mouse blastocysts. Fertil. Steril. 83:238-42
128. Vermot J, Niederreither K, Garnier JM, Chambon P, Dollé P. 2003. Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice. Proc. Natl. Acad. Sci. USA 100:1763-68
129. Mulder GB, Manley N, Maggio-Price L. 1998. Retinoic acid-induced thymic abnormalities in the mouse are associated with altered pharyngeal morphology, thymocyte maturation defects, and altered expression of Hoxa3 and Pax1. Teratology 58:263-75
130. KnudsenPA. 1967. Dental malformations in rat embryos with exencephaly induced by hypervitaminosis A. Acta Odontol. Scand. 25:267-87
131. Alles AJ, Sulik KK. 1990. Retinoic acid-induced spina bifida: evidence for a pathogenetic mechanism. Development 108:73-81
132. Elmazar MM, Nau H. 2004. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands. Arch. Toxicol. 78:660-68
133. Mic FA, Haselbeck RJ, Cuenca AE, Duester G. 2002. Novel retinoic acid generating activities in the neural tube and heart identified by conditional rescue of Raldh2 null mutant mice. Development 129:2271-82
134. Mic FA, Molotkov A, Benbrook DM, Duester G. 2003. Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis. Proc. Natl. Acad. Sci. USA 100:7135-40
135. Durand B, Saunders M, Gaudon C, Roy B, Losson R, et al. 1994. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBOJ. 13:5370-82
136. Roy B, Taneja R, Chambon P. 1995. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by a RAR receptor a (RARα)-, RARβ- or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol. Cell. Biol. 15:6481-87
137. Taneja R, Bouillet P, Boylan JF, Gaub MP, Roy B, et al. 1995. Reexpression of retinoic acid receptor (RAR) gamma or overexpression of RAR alpha or RAR beta in RAR gamma-null F9 cells reveals a partial functional redundancy between the three RAR types. Proc. Natl. Acad. Sci. USA 92:7854-58
138. Taneja R, Roy B, Plassat JL, Zusi CF, Ostrowski J, et al. 1996. Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc. Natl. Acad. Sci. USA 93:6197-202
139. Brookfield J. 1992. Can genes be truly redundant? Curr. Biol. 2:553-54
140. Thomas JH. 1993. Thinking about genetic redundancy. Trends Genet. 9:395-99
141. Lee SS, Gonzalez FJ. 1996. Targeted disruption of the peroxisome proliferator-activated receptor alpha gene, PPAR alpha. Ann. NY Acad. Sci. 804:524-29
142. Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, et al. 2000. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol. Cell. Biol. 20:5119-28
143. Flamant F, Samarut J. 2003. Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol. Metab. 14:85-90
144. Kato S. 2000. The function of vitamin D receptor in vitamin D action. J. Biochem. (Tokyo) 127:717-22
145. Peet DJ, Janowski BA, Mangelsdorf DJ. 1998. The LXRs: a new class of oxysterol receptors. Curr. Opin. Genet. Dev. 8:571-75
146. Sinal CJ, Tonkin M, Miyata M, Ward JM, Lambert G, et al. 2000. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102:731-44
147. Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, et al. 2001. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. USA 98:3369-74
148. Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, et al. 2001. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc. Natl. Acad. Sci. USA 98:3375-80
149. Wei P, Zhang J, Egan-Hafley M, Liang S, Moore DD. 2000. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407:920-23
150. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, et al. 1999. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell. 4:585-95
151. Metzger D, Indra AK, Li M, Chapellier B, Calleja C, et al. 2003. Targeted conditional somatic mutagenesis in the mouse: temporally-controlled knock out of retinoid receptors in epidermal keratinocytes. Methods Enzymol. 364:379-408
152. Li M, Indra AK, Warot X, Brocard J, Messaddeq N, et al. 2000. Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis. Nature 407:633-36
153. Li M, Chiba H, Warot X, Messaddeq N, Gérard C, et al. 2001. RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 128:675-88
154. Chapellier B, Mark M, Messaddeq N, Calleja C, Warot X, et al. 2002. Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled. EMBO J. 21:3402-13
155. Imai T, Jiang M, Chambon P, Metzger D. 2001. Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. Proc. Natl. Acad. Sci. USA 98:224-28
156. Imai T, Takakuwa R, Marchand S, Dentz E, Bornert JM, et al. 2004. Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc. Natl. Acad. Sci. USA 101:4543-47
157. Imai T, Jiang M, Kastner P, Chambon P, Metzger D. 2001. Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity. Proc. Natl. Acad. Sci. USA 98:4581-86
158. Li E, Sucov HM, Lee KF, Evans RM, Jaenisch R. 1993. Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene. Proc. Natl. Acad. Sci. USA 90:1590-94
159. Krezel W, Ghyselinck N, Samad TA, Dupé V, Kastner P, et al. 1998. Impaired locomotion and dopamine signalling in retinoid receptor mutant mice. Science 279:863-67
160. Chiang MY, Misner D, Kempermann G, Schikorski T, Giguere V, et al. 1998. An essential role for retinoid receptors RARbeta and RXRgamma in long-term potentiation and depression. Neuron 21:1353-61
161. Brown NS, Smart A, Sharma V, Brinkmeier ML, Greenlee L, et al. 2000. Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse. J. Clin. Invest. 106:73-79